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Carotenoid pigments (CP) are natural compounds which impart to the tissues where 
they occur, a yellow, orange, red and even blue color. They are precursors of 
vitamins A, B12, D3 and can not be biosynthesized by any animal taxonomic group 
including man. In plants they avoid chlorophyll bleaching and destruction of some 
biological active substances like citocroms, peroxidases, catalase, flavonoidic 
pigments, vitamins B12, E, K etc./1/. They are used in cosmetics, in aquaculture, 
poultry farming, in food industry as antioxidants and natural colorants for drinks 
and dairy products, as fodder additives for color, organoleptic and biological 
qualities improvement. Due to the restrictive use in food industry or as fodder 
additives of the synthetically obtained CP, though they are less expensive, the 
biotechnologies based on carotenogenic yeasts, in particular for astaxanthin 
production, are now reconsidered even if the bioprocesses are more costly. New 
sources identification and economic efficiency and feasibility of CP obtainment 
processes are a constant challenge, especially since recent studies pointed out CP 
role in medicine for prevention and treatment of some chronic maladies like cancer, 
arteriosclerosis, cataract, cardiovascular diseases, immunodeficiency’s syndromes, 
brain dysfunctions, etc./2-4/. with a great occurrence in human population. This 
paper presents a technological model at laboratory scale for the red-violaceus 
pigment Astaxanthin (3,3
'-dehidroxy-β,β
'-caroten-4,4
'dione) obtainment with the 
Sporobolomycetous yeast Xanthophyllomyces dendrorhous DSMZ 5626 [ICCF 
338].The yeast was screened for genetic purity and media and cultivating conditions 
were studied. The pigment was extracted and separated chromatographically from 
the alkaline treated wet biomass, for cell wall disruption. The separated Astaxanthin 
was diluted with sunflower oil up to a content of 50 μg/ml. The product can be 
conditioned as soft capsules, or as it is as food supplement for human and veterinary 
use. 
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Introduction 
 
The purpose of this study is to obtain the astaxanthin by biosynthesis and 
extraction from the yeast Xanthophyllomyces dendrorhous DSMZ 5626 [ICCF 
338] culture. The studies and results are in the field of microbiology, 
biotechnology, analytical chemistry and pharmacology. 
 
Materials and Methods 
 
1. Microbiology: The strain Xanthophyllomyces dendrorhous DSMZ 5626 
was purchased as vegetative culture on slant from German Collection of 
Microorganisms and Cell Cultures, purified by loop wearing method and serial 
decimal dilutions (Photo 1). A pink-violaceus colony (1
strow) was isolated and 
cultivated on slants with YMPG agar media (used as preinoculum), in Erlenmeyer 
flasks with YMPG liquid sterile medium (as inoculum) and in a MICROFERM 
vessel for bioprocess. At the end of bioprocess, the culture was maintained in the 
vessel for 2 days in the day light without stirring and aerated with sterile air. Cells 
from the liquid culture were harvested by centrifugation, rinsed and used in the 
following technological studies. 
 
2.  Biotechnology:  For the extraction of carotenoids produced by 
Xanthophyllomyces dendrorhous DSMZ 5626 [ICCF 338] it was used the organic 
solvent extraction method (ethanol, methanol, acetone). In the same technological 
step it was realized a mild alcaline hydrolysis of the esterified carotenoids. After 
the waste cells separation, the free carotenoids were reextracted in organic 
solvents, concentrated and separated by absorption chromatography on silicagel 
mixed whit CaCO3 and MgCO3 (1:1). The mobile phase was eliminated by 
distillation under nitrogen protection. 
 
3. Analytical methods: Carotenoids were identified and their content in the 
extract and in the eluate was determined spectrophotometrically by means of 
lambda max and by thin-layer chromatography (solvents: acetone and hexane)  
 
4. Pharmacology: The obtained astaxanthin (Sample A and B), astaxanthin 
standard (from Merck&Co) and a reference substance – Antioxidant complex (β-
carotene, A vitamine, selenium and chrome), a product of Harmony Line Co, were 
examined for their antioxidant activity. We used  liver homogenates (in phosphate 
buffer saline) from Wistar rats (160 ± 5 g) treated with CCl4 (2ml/kg) in sunflower 
oil. Liver homogenates from animals treated with sunflower only served as control. 
Homogenate samples (2 ml), treated with test compounds in different doses (10 
and 30 µg/ml respective), where processed for MDA (malonedialadehie) 
determination on the basis of the presence of TBARS (thiobarbituric acid reactive 
substance).  The amount of peroxides formed was spectrophotometrically 
determined by measuring absorbance at 535 nm.    160
Results and Discutions 
 
1. Microbiology: The authenticity and culture purity tests performed by loop 
wearing method and serial decimal dilutions in Petri dish are presented in Photo 1. 
 Photo 1. Authenticity and culture 
purity tests by the loop wearing 
method 
 
1
strow: PDA+0,5%yeast extract. It was 
the only medium formula on which two 
kinds of colonies differentiated: the 
majority-dull pink-violaceus with a 
white surrounding halo of hypha and a 
glossy slimy violaceus colony, out of 
which  Xanthophyllomyces dendrorhous 
DSMZ 5626 [ICCF 338] was further 
isolated and utilized. 
2
ndrow: YMPG agar, soluble starch agar, 
BW agar-on which only the pink 
colonies whit extended halos developed 
 
2. Biotechnology: Based on our biotechnological studies it was designed a 
method for astaxanthin obtainment from cells of Xanthophyllomyces dendrorhous 
DSMZ 5626 [ICCF 338], on 6 steps: a) extraction and hydrolysis of the esterifies 
carotenoids, b) separation of the extracts from the waste cells, c) reextraction of the 
free carotenoids in organic solvents, d) separation of the pigments by absorption 
chromatography, e) removal of the mobile phase, f) drying of the final product. 
 
3. Analytical : Figure 1 shows the VIS spectra of astaxanthin standard (from 
Merck&Co) (on botom) and of two samples with extracted carotenoids. The 
samples contain astaxanthin and also other carotenoids. Figure 2 shows a TLC 
plate of 4 extracts from different phases of the bioprocess (1,2,3,5). Astaxanthin 
(Rf=0,16) and Canthaxanthin (Rf=0,49) standards were applied in the 4
th spot. The 
plate reveals the presence of astaxathin (on 2 
nd spot) between several carotenoids. 
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                     1    2     3    4    5 
Fig.1-VIS spectra of studied carotenoids Fig.2-TLC plate of studied carotenoids 
 
4. Pharmacology: The results  of the antioxidant activity evaluation are 
presented in Table 1. 
Table 1- The inhibition of lipid peroxidation  
Sample  A 535 nm % antioxidant 
activity 
Negative control   0,864  - 
Positive control (intoxicated with CCl4) 0,658  - 
Positive control + 10 g Antioxidant cx.  0,840 88 
Positive control + 30 g Antioxidant cx.  0,847  92 
Positive control + 10 g Astaxantina et.  0,817 77 
Positive control + 30 g Astaxantina et.  0,841  89 
Positive control + 10 g Sample A  0,790 64 
Positive control + 30 g Sample A  0,838  87 
Positive control + 10 g Sample B  0,738 39 
Positive control + 30 g Sample B  0,812  75 
 
 
Conclusions 
 
From  Xanthophyllomyces dendrorhous  DSMZ 5626, were isolated and 
characterized three different strains: Xanthophyllomyces dendrorhous ICCF 338, 
Sporobolomyces holstaticus ICCF 371, Sporobolomyces salmonicolor (syn. S. 
albo-rubescens, S.photographus) ICCF 370. 
For  Xanthophyllomyces dendrorhous ICCF 338 was studied the optimum 
conditions of cultivation in preinoculum, inoculum and bioprocess phases.   162
Processing the Xanthophyllomyces dendrorhous ICCF 338 biomass by the 
method presented above, we have obtained astaxanthin whose antioxidant activity 
(87% protection) is similar to the Merck&Co standard (89% protection) and to the 
reference commercial product from Harmony Line Co (92% protection) whose 
formula is far more complex. 
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Pigmenţii carotenoidici sunt substanţe naturale care, datorită structurii lor chimice, 
imprimă ţesuturilor în care apar o culoare galbenă, portocalie, roşie sau chiar albastră. Ei 
sunt precursori ai vitaminelor A, B12, D3 şi nu pot fi biosintetizaţi de organismele animale. 
În plante au rolul de a apăra clorofila şi alte substanţe biologic active precum citocromii, 
peroxidazele, catalaza, pigmenţii flavonoidici, vitaminele B12, E, K, etc. Sunt folosiţi în 
cosmetică, piscicultură, avicultură, în industria alimentară ca antioxidanţi  şi coloranţi 
naturali pentru băuturi  şi produse lactate, ca aditivi alimentari pentru a colora şi a 
îmbunătăţi calităţile organoleptice şi biologice ale produselor. Cu toate că preţul de 
fabricaţie al carotenoidelor de sinteză este scăzut, datorită restricţiilor impuse la utilizarea 
lor în industria alimentară, biotehnologiile bazate pe cultivarea drojdiilor carotenogene, în 
particular a celor pentru producerea Astaxantinei, sunt acum reconsiderate chiar dacă 
momentan sunt mai costisitoare. 
Un interes deosebit este manifestat în ultimul timp în direcţia identificării de noi surse de 
obţinere a pigmenţilor carotenoidici în condiţii de eficienţă, deoarece studii recente au scos 
în evidenţă unele oportunităţi legate de utilizarea acestora în medicina umană şi veterinară 
pentru prevenirea şi trararea unor maladii cronice, inclusiv a cancerului, ateriosclerozei, 
cataractei, a bolilor cardiovasculare, a imunodeficienţelor, a unor disfuncţii cerebrale, 
etc., maladii cu o mare incidenţă în rândul populaţiei.Lucrarea prezintă un model 
tehnologic realizat la nivel laborator privind obţinerea Astaxantinei (3,3
'-dehidroxy-β,β
'-
caroten-4,4
'diona), pigment roşu-violaceu prin intermediul drojdiei Xanthophyllomyces 
dendrorhous  DMSZ 5626 [ICCF 338].Drojdia a fost controlată din punct de vedere al 
purităţii genetice, au fost studiate compoziţiile de medii şi condiţiile optime de cultivare, iar 
pigmenţii extraşi prin hidroliza alcalină a biomasei au fost separaţi cromatografic. 
Astaxantina separată a fost reluată în ulei de foarea soarelui până la un conţinut de 50 
μg/ml. Produsul poate fi condiţionat sub formă de capsule gelatinoase sau utilizat ca atare 
drept supliment alimentar de uz uman şi veterinar. 
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